146 related articles for article (PubMed ID: 10831158)
1. Differential growth inhibitory effect of melatonin on two endometrial cancer cell lines.
Kanishi Y; Kobayashi Y; Noda S; Ishizuka B; Saito K
J Pineal Res; 2000 May; 28(4):227-33. PubMed ID: 10831158
[TBL] [Abstract][Full Text] [Related]
2. Potential involvement of mt1 receptor and attenuated sex steroid-induced calcium influx in the direct anti-proliferative action of melatonin on androgen-responsive LNCaP human prostate cancer cells.
Xi SC; Tam PC; Brown GM; Pang SF; Shiu SY
J Pineal Res; 2000 Oct; 29(3):172-83. PubMed ID: 11034115
[TBL] [Abstract][Full Text] [Related]
3. Melatonin binding sites in estrogen receptor-positive cells derived from human endometrial cancer.
Kobayashi Y; Itoh MT; Kondo H; Okuma Y; Sato S; Kanishi Y; Hamada N; Kiguchi K; Ishizuka B
J Pineal Res; 2003 Sep; 35(2):71-4. PubMed ID: 12887647
[TBL] [Abstract][Full Text] [Related]
4. The rat endometrial adenocarcinoma cell line RUCA-I: a novel hormone-responsive in vivo/in vitro tumor model.
Vollmer G; Schneider MR
J Steroid Biochem Mol Biol; 1996 Apr; 58(1):103-15. PubMed ID: 8809192
[TBL] [Abstract][Full Text] [Related]
5. MT(1) melatonin receptor overexpression enhances the growth suppressive effect of melatonin in human breast cancer cells.
Yuan L; Collins AR; Dai J; Dubocovich ML; Hill SM
Mol Cell Endocrinol; 2002 Jun; 192(1-2):147-56. PubMed ID: 12088876
[TBL] [Abstract][Full Text] [Related]
6. Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression.
Leong H; Firestone GL; Bjeldanes LF
Carcinogenesis; 2001 Nov; 22(11):1809-17. PubMed ID: 11698343
[TBL] [Abstract][Full Text] [Related]
7. The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system.
Hill SM; Spriggs LL; Simon MA; Muraoka H; Blask DE
Cancer Lett; 1992 Jul; 64(3):249-56. PubMed ID: 1638517
[TBL] [Abstract][Full Text] [Related]
8. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
Bhat KP; Pezzuto JM
Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
[TBL] [Abstract][Full Text] [Related]
9. Acetaminophen exhibits weak antiestrogenic activity in human endometrial adenocarcinoma (Ishikawa) cells.
Dowdy J; Brower S; Miller MR
Toxicol Sci; 2003 Mar; 72(1):57-65. PubMed ID: 12604834
[TBL] [Abstract][Full Text] [Related]
10. Metformin inhibits 17β-estradiol-induced epithelial-to-mesenchymal transition via βKlotho-related ERK1/2 signaling and AMPKα signaling in endometrial adenocarcinoma cells.
Liu Z; Qi S; Zhao X; Li M; Ding S; Lu J; Zhang H
Oncotarget; 2016 Apr; 7(16):21315-31. PubMed ID: 26824324
[TBL] [Abstract][Full Text] [Related]
11. Melatonin blocks the activation of estrogen receptor for DNA binding.
Rato AG; Pedrero JG; Martinez MA; del Rio B; Lazo PS; Ramos S
FASEB J; 1999 May; 13(8):857-68. PubMed ID: 10224229
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of estrogen and antiestrogen on transforming growth factor gene expression in endometrial adenocarcinoma cells.
Gong Y; Ballejo G; Murphy LC; Murphy LJ
Cancer Res; 1992 Apr; 52(7):1704-9. PubMed ID: 1551100
[TBL] [Abstract][Full Text] [Related]
13. Estrogen and aryl hydrocarbon receptor expression and crosstalk in human Ishikawa endometrial cancer cells.
Wormke M; Castro-Rivera E; Chen I; Safe S
J Steroid Biochem Mol Biol; 2000 Apr; 72(5):197-207. PubMed ID: 10822009
[TBL] [Abstract][Full Text] [Related]
14. Tracking the elusive antiestrogenic effect of melatonin: a new methodological approach.
Girgert R; Bartsch C; Hill SM; Kreienberg R; Hanf V
Neuro Endocrinol Lett; 2003 Dec; 24(6):440-4. PubMed ID: 15073572
[TBL] [Abstract][Full Text] [Related]
15. Differential responsiveness of MCF-7 human breast cancer cell line stocks to the pineal hormone, melatonin.
Ram PT; Yuan L; Dai J; Kiefer T; Klotz DM; Spriggs LL; Hill SM
J Pineal Res; 2000 May; 28(4):210-8. PubMed ID: 10831156
[TBL] [Abstract][Full Text] [Related]
16. Receptor mediated antiproliferative effects of the cytotoxic LHRH agonist AN-152 in human ovarian and endometrial cancer cell lines.
Westphalen S; Kotulla G; Kaiser F; Krauss W; Werning G; Elsasser HP; Nagy A; Schulz KD; Grundker C; Schally AV; Emons G
Int J Oncol; 2000 Nov; 17(5):1063-9. PubMed ID: 11029513
[TBL] [Abstract][Full Text] [Related]
17. The effects of estradiol and selective estrogen receptor modulators on gene expression and messenger RNA stability in immortalized sheep endometrial stromal cells and human endometrial adenocarcinoma cells.
Farnell YZ; Ing NH
J Steroid Biochem Mol Biol; 2003 Mar; 84(4):453-61. PubMed ID: 12732290
[TBL] [Abstract][Full Text] [Related]
18. Non-nuclear activation of signal transducer and activator of transcription 3 by 17β- estradiol in endometrial cancer cells.
Guo RX; Zhang RF; Wang XY; Li LX; Shi HR; Qiao YH
Neoplasma; 2011; 58(6):532-7. PubMed ID: 21895407
[TBL] [Abstract][Full Text] [Related]
19. Direct growth inhibition of human endometrial cancer cells by the gonadotropin-releasing hormone antagonist SB-75: role of apoptosis.
Kleinman D; Douvdevani A; Schally AV; Levy J; Sharoni Y
Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):96-102. PubMed ID: 8296852
[TBL] [Abstract][Full Text] [Related]
20. Role of estrogen and estrogen-related growth factor in the mechanism of hormone dependency of endometrial carcinoma cells.
Hata H; Hamano M; Watanabe J; Kuramoto H
Oncology; 1998 Dec; 55 Suppl 1():35-44. PubMed ID: 9852400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
